How are COVID vaccine deployments going in Europe?


Issues with the rollout of the COVID-19 vaccine in the United States have grabbed headlines. But, as the old saying goes, the grass isn’t always greener on the other side, even if we’re talking across the Atlantic. European countries also face challenges. In this Motley Fool live Video recorded January 13, 2021, Corinne Cardina, Office of Health and Cannabis Chief, and Keith Speights, writer, discuss the progress of the COVID-19 vaccine rollout in Europe.

Corinne Cardin: Let’s look abroad momentarily. How is it going with the regulations and the deployment of the vaccine in Europe?

Keith Speights: Well, in Europe, and when we say Europe, you have to make a difference there, Corinne, because you have the countries of the European Union and then you have the United Kingdom, which is no longer part of the ‘European Union. There are two different factors at play there.

In the UK, they have licensed three vaccines so far. They first started with the Pfizer (DFP 2.00%)BioNTech (BNTX 0.33%) vaccine, then they gave permission to Modernit is (ARNM 4.68%) vaccine and also Astra Zenecait is (AZN 1.15%) vaccine they developed with the University of Oxford. The UK has three vaccines that are being rolled out. In the European Union, there are two vaccines, the Pfizer BioNTech vaccine and the Moderna vaccine.

The population of Europe, including the EU countries and the UK combined, is over 500 million people. They face the same kind of problems as the United States. Some countries have said they don’t have enough health personnel to get all the vaccines out, they are behind schedule they had hoped for.

They even see some of the same issues that we just talked about with the federal government in the United States and the states that have disconnects there. Well, the European Union is, you can think of it as a federal government in a way with each country as a state. There were communication problems between the EU and the different countries. They run into some of these logistical issues. Their process is moving slowly, just like in the United States. But just as we see things improving in the United States, I think we will see it in Europe as well.


About Author

Comments are closed.